Rein Therapeutics (RNTX) Cash flow

1,206 Followers

Rein Therapeutics Cash Flow

RNTX's free cash flow for Q4 2025 was $-3.22M. For the 2025 fiscal year, RNTX's free cash flow was decreased by $2.93M and operating cash flow was $-3.22M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Mar 25	Mar 24	Mar 23	Dec 21
Operating Cash Flow	$ -19.36M	$ -22.29M	$ -19.81M	$ -24.86M	$ -23.75M
Investing Cash Flow	$ 0.00	$ 0.00	$ 16.20M	$ 26.46M	$ -35.92M
Financing Cash Flow	$ 9.76M	$ 17.82M	$ 15.79M	$ 0.00	$ 55.66M
End Cash Position	$ 3.21M	$ 12.87M	$ 17.34M	$ 5.22M	$ 3.63M
Free Cash Flow	$ -19.36M	$ -22.29M	$ -19.81M	$ -24.86M	$ -23.91M

Currency in USD